12
Participants
Start Date
October 31, 2007
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
MVA85A
Vaccine. Dose: 1 x 10\^8 plaque-forming units (pfu) given by intradermal injection into the deltoid region of the upper arm.
Deuterated glucose infusion
6,6D2-glucose given as a timed intravenous infusion. The total dose of deuterated glucose will be 1g/kg volunteer body weight (up to a maximum of 60g).
University of Oxford, Oxford
Wellcome Trust
OTHER
St George's, University of London
OTHER
University of Oxford
OTHER